Recent General Thyroid Cancer News

Pass it On: It’s National Thyroid Awareness Month (September 8, 2017)

The thyroid gland is a butterfly-shaped organ that is below the Adam’s apple in the front part of the neck. It produces, stores, and releases hormones that regulate vital body functions. Thyroid cancer... Continue Reading

Nexavar Approved for Metastatic Differentiated Thyroid Cancer (December 9, 2013)

The U.S. Food and Drug Administration (FDA) has approved Nexavar® (sorafenib) for the treatment of metastatic differentiated thyroid cancer. Differentiated thyroid cancer is the most common type of thyroid... Continue Reading

Mutations Linked to Drug Response in Medullary Thyroid Cancer (November 15, 2013)

Metastatic medullary thyroid cancers with certain genetic mutations respond better to treatment with Cometriq™ (cabozantinib) than tumors without those mutations, according to the results of a study... Continue Reading

TSH Suppression after Thyroidectomy May Not Be Beneficial (November 4, 2013)

Suppression of thyroid-stimulating hormone (TSH) after thyroidectomy for low-risk cancer does not appear to reduce the risk of cancer recurrence and may even increase the risk of osteoporosis in women,... Continue Reading

Thyroid Ultrasound May Cut Biopsy Rate (September 13, 2013)

Thyroid ultrasound may help identify certain characteristics of thyroid nodules that can predict the likelihood of cancer—and subsequently help determine whether biopsy is necessary, according to the... Continue Reading

BRAF V600E mutation Increases Death Risk in Papillary Thyroid Cancer (June 5, 2013)

The presence of the BRAF V600E mutation is significantly associated with increased cancer-related death among patients with papillary thyroid cancer, according to the results of a study published in... Continue Reading

Selumetinib May Reverse Radioiodine Resistance in Advance Thyroid Cancer (March 28, 2013)

The experimental drug selumetinib (AZD6244) may help some patients with advanced thyroid cancer overcome resistance to radioiodine, which is the most effective treatment for the disease, according to the... Continue Reading

Targeted Drug Caprelsa Slows Thyroid Cancer (August 30, 2012)

The targeted drug Caprelsa® (vandetanib) delays progression in advanced differentiated thyroid cancer, according to the results of a study published in The Lancet Oncology. The thyroid is a gland in... Continue Reading

Gene Expression Test Identifies Low-Risk Thyroid Nodules (June 28, 2012)

A new test measures gene expression in thyroid nodules with inconclusive biopsy results and helps identify low-risk nodules, thereby preventing unnecessary surgeries, according to the results of a study... Continue Reading

Low-Dose Radioiodine Effective in Thyroid Cancer (May 10, 2012)

Low-dose radioiodine is as effective as high-dose in the treatment of thyroid cancer, according to the results of two separate studies published in the New England Journal of Medicine. The results mean... Continue Reading

Next Page »